Active Ingredient(s):Pegvisomant FDA Approved: * March 25, 2003 Pharm Company: *PHARMACIA AND UPJOHN Category:Acromegaly
Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.[1] It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy.[2] It is delivered as a powder that is mixed with water and injected under the skin.[3]
Contents
1 Discovery
2 Struct...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.
